Compare IDYA & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | DHT |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 2.9B |
| IPO Year | 2019 | 2005 |
| Metric | IDYA | DHT |
|---|---|---|
| Price | $35.87 | $17.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 3 |
| Target Price | ★ $52.86 | $19.33 |
| AVG Volume (30 Days) | 1.4M | ★ 3.9M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 5.36% |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $218,710,000.00 | N/A |
| Revenue This Year | N/A | $8.85 |
| Revenue Next Year | $201.05 | N/A |
| P/E Ratio | ★ N/A | $12.73 |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $21.33 | $10.61 |
| 52 Week High | $40.58 | $20.55 |
| Indicator | IDYA | DHT |
|---|---|---|
| Relative Strength Index (RSI) | 50.34 | 47.75 |
| Support Level | $32.85 | $17.14 |
| Resistance Level | $38.17 | $18.80 |
| Average True Range (ATR) | 1.45 | 0.69 |
| MACD | -0.47 | 0.02 |
| Stochastic Oscillator | 4.70 | 45.23 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
DHT Holdings Inc is a crude oil tanker company. The company's primary business is operating a fleet of crude oil tankers, with a secondary activity of providing technical management services. Its fleet trades internationally and consists of VLCC crude oil tankers. The group generates revenues from time charter and spot market operations. It operates vessels through its subsidiary management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from Voyage charter revenues.